Skip to main content
editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
American Journal of Pharmacy and Health Research

American Journal of Pharmacy and Health Research

📢 Latest Update: Call for Papers 2026 | Submit Your Research to an International Peer-Reviewed Open Access Pharmacy Journal

📢 Latest Update: Call for Papers 2026 | Submit Your Research to an International Peer-Reviewed Open Access Pharmacy Journal

Volume 13, Issue 10 - 2025 (October 2025 Issue 10)

Volume 13 Issue 10 Cover

Issue Details:

Volume 13 Issue 10
Published:Apr 2, 2026

Dr H J Patel
Editor in Chief
American Journal of Pharmacy and Health Research

Articles in This Issue

Showing 1 of 1 articles
Research PaperID: AJPHR1310001Pages 1-4Open AccessOpen Access

Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction

Dr. Namitha Rachel Biji, Prof. Dr. S.K Mathew, Dr. Dhanu Josey, Dr. Joseph John

ABSTRACTDapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin. Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.

SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.
112,000 views
33,690 downloads

Contributors:

 Dr. Namitha Rachel Biji
,
 Prof. Dr. S.K Mathew
,
 Dr. Dhanu Josey
,
 Dr. Joseph John
Whatsapp